PlumX Metrics
Embed PlumX Metrics

Asymptomatic left ventricle systolic dysfunction

European Cardiology Review, ISSN: 1758-3764, Vol: 15, Page: e13
2020
  • 25
    Citations
  • 0
    Usage
  • 33
    Captures
  • 56
    Mentions
  • 1
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    25
  • Captures
    33
  • Mentions
    56
    • News Mentions
      56
      • News
        56
  • Social Media
    1
    • Shares, Likes & Comments
      1
      • Facebook
        1

Most Recent News

Anumana and AliveCor Collaborate to Advance ECG-AI Algorithms for Early Detection of Cardiac Diseases on Kardia Devices

Classified in: Science and technology Subject: Product/Service Anumana, a leading AI-driven health technology company, today announced a collaboration with AliveCor to develop Anumana's advanced AI

Article Description

Heart failure is a common debilitating illness, associated with significant morbidity and mortality, rehospitalisation and societal costs. Current guidelines and position statements emphasise the management of patients with overt symptomatic disease, but the increasing prevalence of congestive heart failure underscores the need to identify and manage patients with early left ventricular dysfunction prior to symptom onset. Asymptomatic left ventricular systolic dysfunction (ALVSD), classified as stage B heart failure, is defined as depressed left ventricular systolic function in the absence of clinical heart failure. Early initiation of therapies in patients with presumed ALVSD has been shown to lead to better outcomes. In this article, the authors clarify issues surrounding the definition and natural history of ALVSD, outline clinical tools that may be of value in identifying patients with ALVSD and highlight potential opportunities for future investigations to better address aspects of our understanding of this complex syndrome.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know